Stay updated with breaking news from Cytek Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FREMONT, Calif., Feb. 28, 2024 -- Cytek® Biosciences, Inc. , a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2023....
Key Insights Given the large stake in the stock by institutions, Cytek Biosciences' stock price might be vulnerable to...
FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell anal...
FREMONT, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30, 2023.
SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 -- DiaSorin and Cytek Biosciences, Inc. today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the... | February 28, 2023